StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CNBX Pharmaceuticals's enterprise value was $331.88K on Oct 19, 2026, against $206.47K a year earlier. Over the last 5 years it ranged from -$54.12K to $2.36B, with a median of $219.36K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$331.88K+60.7%
2025Dec 31, 2025$206.47K+1.3%
2024Dec 31, 2024$203.81K+6.5%
2023Dec 29, 2023$191.39K-91.2%
2022Dec 30, 2022$2.19M-99.8%
2021Dec 31, 2021$1.40B-58.5%
2020Dec 31, 2020$3.38B+71.1%
2019Dec 31, 2019$1.97B-53.4%
2018Dec 31, 2018$4.23B-83.7%
2017Dec 29, 2017$25.96B+194.8%
2016Dec 30, 2016$8.81B+1226.8%
2015Dec 31, 2015$663.84M-80.3%
2014Dec 31, 2014$3.37B+58850.7%
2013Dec 31, 2013$5.71M-58.8%
2012Dec 31, 2012$13.88M–

More CNBX Pharmaceuticals figures

See a number that looks wrong?